The biomolecular interface and the definition of living

Definitional and classification issues often arise in any field of heightened focus and progress (e.g.; what is a planet?). For the many fields integrating organic and inorganic materials, an interesting issue comes up as to what is the definition of life. Many different gradations of living things are emerging.

Some interesting new cases of living materials are the idea of organic sensors made of biomaterial placed on buildings, self-replicating crystals and biological scaffolding for stem cell grown organs and 3D tissue printing.

De novo materials synthesis
One exciting aspect of the living/non-living classification is the new synthesis of both organic and inorganic materials. Scientists are creating de novo engineered proteins and other biological materials, non-naturally occurring inorganic materials with superior properties using molecular manufacturing techniques and hybrid organic-inorganic materials, with the best of organic and inorganic properties in one object, for example rotaxanes which could be used in quantum computing.

Definition of integration
Not just the definition of what is living arises, but also the definition of the integration of organic and inorganic materials. Alan H. Goldstein proposes that a true integration of organic and inorganic material involves communicating back and forth, not just a system which has properties or components of both organic and inorganic systems.

The future of biomolecular interfaces

The future of biomolecular interfaces is probably a further blurring of the underlying substrates as the focus is more relevantly on the properties and requirements of any challenge at hand.

Foundations of bio-info tech convergence

The most important thing that became clear at last week’s 2nd annual Unither Nanomedical & Telemedical Technology Conference is that many different foundational technologies are starting to be in place for bio-info tech convergence. Ray Kurzweil and others herald the eventual re-engineering of humans into technology that can learn and evolve as fast as infotech but may not realize pathways for bio-info tech convergence are already underway.

Boundaries and definitions of organic and inorganic, natural and synthesized, biological and electronic are blurring into a variety of permutations.

It is almost becoming anachronistic to talk about bio-info convergence when the focus in some fields has already progressed to resolving the problems at hand with the available tools which may include any variety of organic, inorganic and hybrid models.

Three key areas with developments underway:

1. Nanoparticle drug delivery systems
With 5 million people receiving some sort of cancer radiation therapy worldwide each year, and cancer quickly becoming a major killer in developing as well as industrialized countries, improvements in diagnosis and treatment are sought. The nextgen standard could be nanoparticle drug delivery systems (diagnosis is still too challenging of a problem in comparison), which could be used independently or in combination with existing radiation technologies to ameliorate treatment. Many different types of nanoparticles (carbon nanotubes, calcium phosphate, gold and various magnetic nanoparticles) and related technologies such as minimally invasive nanoXrays are under development.

2. Implanted monitors and body area networking
The most obvious case of human-device integration is pacemakers (500,000 are implanted worldwide annually). The latest versions feature one-way broadcast with the devices communicating information externally to physicians for remote monitoring; wireless heart sensors currently have an installed base in the U.S. of over 150,000. Human wireless sensing is further conceptualized as body area networking, which mainly means sensors that are internal or external to the body transmitting data one-way. The IEEE working standard for this communication is 802.15.6. The next steps would be enabling two-way broadcast, bringing some light processing on-board the implanted or external body sensors and later, augmentation. Brain-computer interfaces (BCIs) are developing in lockstep.

3. Powering implants: one idea is the ATP chip
One of the biggest challenges with devices implanted in the body is energy; providing adequate ongoing power to the device. Power trumps the other two concerns: bandwidth and biocompatibility. Many interesting methods of power generation are being investigated including thermal and vibrational energy, RF, light/PV, biochemical energy and the ATP chip, possibly getting nanodevices to produce ATP from naturally circulating glucose.

Apparently no one is yet considering the human bacterial biome as a therapeutic or augmentation platform but this could be another interesting means of bio-info tech convergence.